Research > ETFs > ETF / ETP Commentary > 

AI Stocks Ready to Rediscover Momentum

The Nasdaq-100 Index (NDX) is higher by 2.51% over the past month. Clearly, growth stocks benefited from the Federal Reserve lowering interest rates for the first time in four years. That could indicate the start of a rebound for various artificial intelligence (AI) equities.Count the NDX-tracking Invesco QQQ Trust (QQQ B+) and the Invesco NASDAQ 100 ETF (QQQM B) as among the exchange traded funds poised to benefit from a potential resurgence by AI stocks. There’s evidence that rebound has started. However, following July, QQQ and QQQM still have room to return to prior highs. Surprisingly, since mid-July about a dozen of the worst-performing domestic large-cap stocks are names with AI ties. QQQ and QQQM holds all of the members of that group. In better news, many of those stocks are snapping out of their summer doldrums.AI Adopters Could Drive QQQ GainsThe AI investment thesis is now in the “show me” phase; investors want more than hype. They want results. Fortunately, results have come in the form of AI adopters spending on QQQ/QQQM member firms such as Nvidia (NVDA). Helped by the recent launch of OpenAI’s Strawberry offering, investors expect AI spending to surge in 2025. That spike could be a boon for a variety of QQQ/QQQM holdings, including Nvidia and Advanced Micro Devices (AMD). “This new o1 model is expected to better handle complex questions and reasoning, with more of a focus on providing thoughtful answers, rather than quick answers,” he says. “From the chip side of things, these types of Strawberry models should require more inference computing power, which continues to support the exponential growth we still anticipate for Nvidia and AMD in AI accelerator chipsets,” noted Morningstar analyst Brian Colello. The research firm noted that Apple (AAPL), Microsoft (MSFT) and Amazon (AMZN) are among the software companies finding ways to monetize AI. Additionally, valuations on select AI names are more appealing today than they were earlier this year. “Drilling down into the individual holdings of the index, 18% of the stocks have Morningstar Ratings- of 1 or 2 stars, meaning they are overvalued according to Morningstar analysts. Fifty-four percent are fairly valued with 3-star ratings, and 28% have ratings of 4 or 5 stars, which means they are considered undervalued,” said Morningstar’s Bella Albrecht. For more news, information, and analysis, visit the ETF Education Channel.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.